NEW YORK, NY — (Marketwired) — 11/06/13 — Healthnostics, Inc. (OTC Pink: HNSS), a medical and biotechnology analytics company, is pleased to provide the following corporate update regarding its recently integrated biomedical web-based operations and expansion of its new business development and acquisition plan.
As a result of the successful corporate actions earlier this year that included a major recapitalization, an upgraded listing on OTC Markets as a current filer, and the operational integration of the Company-s web-based medical and bio-analytics portals, Healthnostics is poised to commence new operations utilizing and in the coming weeks.
The new business development and acquisition focus will be on strategically relevant web-centric businesses that enhance and further the Company-s existing healthcare technology offerings.
About Healthnostics
Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems for acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics- major products include: MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.
For further information please visit Healthnostics .
This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management-s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.
Contact:
Healthnostics, Inc.
Investor Relations
You must be logged in to post a comment Login